source
- STAT+: Pharma’s drug spending deflectionJob lock, surging prescription drug costs, No Surprises Act update, and more from STAT's Health Care Inc.
- STAT+: Sarepta names Michael Severino, former Tessera CEO, as new chief executiveThe beleaguered Sarepta Therapeutics named Michael Severino, who previously led Tessera Therapeutics, as its new CEO.